What to Do With Left Over Mounjaro

Step 1, Work out why the pen is left over

The first question to ask is straightforward: why do you have a spare? The answer shapes everything that follows.

If a pen was left out of the fridge overnight or during travel, the situation is different from one that has been correctly refrigerated the whole time. Tirzepatide pens must be kept at 2–8°C; there is a limited window during which a pen can sit at room temperature and still be used, but the exact duration is set out in the Patient Information Leaflet and the Mounjaro SmPC on the eMC, not here, because that detail matters and generalising it risks harm. If you are unsure whether a pen was out too long, our page on Mounjaro left out overnight covers the storage question specifically.

Other common reasons for leftover stock: a dose increase means the lower-strength pens are now redundant; a pause in treatment (illness, surgery, a holiday); or a prescription was filled but treatment was delayed. Each scenario has a different resolution, so pinning down the reason first saves time.

Step 2, Check whether the pen is still safe to use

A pen that has been refrigerated continuously and is within its expiry date is generally still viable. A pen that left the fridge for an unknown period, or that shows any cloudiness or discolouration when inspected, should not be used. Mounjaro solution is clear and colourless; visible changes are a signal to discard.

Expiry dates are printed on both the outer carton and the pen itself. If you are mid-way through a course and your treatment has paused (over the bank holidays, say, or while recovering from a procedure) the pen's expiry date and storage record are the two things to check before resuming. Do not simply assume a pen is fine because it looks undamaged.

If you have been away and had to store a pen outside normal conditions, bring this up with your prescriber before injecting. The NHS guidance on tirzepatide covers the basics of how to store and use Mounjaro and is worth reading alongside the enclosed leaflet.

Step 3, Decide whether to use, store, or dispose of spare pens

Once you've confirmed a pen is correctly stored and in date, the next question is whether using it fits your current prescription. This is where the process-led approach matters most.

If your dose was recently increased and you have pens at a lower strength left over, you should not use them without speaking to your prescriber first, titration schedules are set clinically, and reverting to a lower dose mid-course is not a decision to make unilaterally. The same applies if you stopped treatment and are considering restarting: a clinical re-review is the right starting point, not simply injecting from old stock. For context on how private prescriptions work and what a clinical review involves, our Mounjaro overview explains the process.

For pens you are not going to use, the correct disposal route is a sharps container, not the household bin or recycling. Many pharmacies accept returned medicines for safe disposal. Passing unused Mounjaro to a friend or family member is not legal or safe, prescriptions are specific to the individual named on them, and the person receiving them would have had no clinical assessment.

On the cost side, it is worth knowing that some people time their repeat orders around payday or before a bank holiday weekend, which can occasionally leave them with overlapping stock; if that is your situation, our guide to Mounjaro pricing covers what goes into a private prescription cost and what to expect.

Step 4, When to contact your prescriber or seek medical advice

Some situations go beyond a storage question and require clinical input. Contact your prescriber if: you have pens at a dose that no longer matches your current prescription; you paused treatment for more than a few weeks and want to restart; or you are uncertain whether an existing pen is still suitable given a change in your health.

Seek prompt medical attention if you experience symptoms that might suggest pancreatitis (severe stomach pain that spreads towards the back, with or without vomiting) regardless of whether you have just used a leftover pen or your regular supply. The MHRA highlighted this risk in a Drug Safety Update in January 2026 and it applies to all tirzepatide treatment, which you can read more about including the tirzepatide logo used to identify genuine packaging, before reporting any suspected adverse reaction via the Yellow Card scheme.

If you have concerns about abdominal pain while on Mounjaro, the page on pain under the left rib on Mounjaro and the separate page on left-side pain cover what symptoms warrant attention. For anything urgent, contact your GP or call 111.

If you are thinking about what the right next step in your treatment looks like, our prescribers are here to help. You can start a free consultation and have your situation reviewed by a GPhC-registered prescriber the same day.